The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status
Top Cited Papers
- 21 September 2001
- journal article
- Published by Elsevier
- Vol. 21 (6) , 251S-272S
- https://doi.org/10.1016/s0197-2456(00)00097-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A national cancer institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancersCancer, 2010
- Quality control of cancer screening examination procedures in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trialControlled Clinical Trials, 2000
- Death review process in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trialControlled Clinical Trials, 2000
- Recruitment strategies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: The first six yearsControlled Clinical Trials, 2000
- Rationale for randomised trials of prostate cancer screeningEuropean Journal Of Cancer, 1999
- Europeans Collaborate on Screening Trials for Prostate CancerJNCI Journal of the National Cancer Institute, 1995
- NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian CancerJAMA, 1995
- NIH Consensus 1994: ScreeningGynecologic Oncology, 1994
- Current Status of Screening for Ovarian CancerGynecologic Oncology, 1994
- Prostate Cancer Screening: What We Know and What We Need To KnowAnnals of Internal Medicine, 1993